BJ
ACAD icon

BlackRock Japan’s Acadia Pharmaceuticals ACAD Stock Holding History

BlackRock Japan’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,845
Closed -$52K – 1416
2016
Q1 		$52K Buy
1,845
+669
+57% +$14.6K ﹤0.01% 1022
2015
Q4 		$42K Buy
1,176
+194
+20% +$6.83K ﹤0.01% 1060
2015
Q3 		$32K Buy
982
+58
+6% +$2.41K ﹤0.01% 1041
2015
Q2 		$39K Buy
924
+191
+26% +$7.39K ﹤0.01% 1110
2015
Q1 		$24K Sell
733
-56
-7% -$1.93K ﹤0.01% 1166
2014
Q4 		$25K Sell
789
-72
-8% -$2.04K ﹤0.01% 1195
2014
Q3 		$21K Buy
861
+146
+20% +$3.41K ﹤0.01% 1156
2014
Q2 		$16K Sell
715
-928
-56% -$19.4K ﹤0.01% 1168
2014
Q1 		$40K Buy
+1,643
New +$41.6K ﹤0.01% 1191

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Japan's ACAD Position: Q2 2016 in Review

BlackRock Japan sold out of Acadia Pharmaceuticals (ACAD) in Q2 2016, closing a stake of 1,845 shares — an estimated $52K sold.

BlackRock Japan first reported a position in ACAD in Q1 2014 and held it in 9 quarters. The position peaked at $52K in Q1 2016. 228 funds tracked by Wall St. Rank hold ACAD as of Q2 2016.

  • BlackRock Japan reported no remaining Acadia Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • BlackRock Japan sold 1,845 Acadia Pharmaceuticals shares in Q2 2016, an estimated $52K.
  • BlackRock Japan first reported a position in Acadia Pharmaceuticals in Q1 2014 and held it in 9 quarters.
  • BlackRock Japan's Acadia Pharmaceuticals position peaked at $52K in Q1 2016.
  • 228 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2016.

Based on BlackRock Japan's 13F filing for Q2 2016, filed 10 Aug 2016.